Status: Recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
The study is a post-authorization, prospective, voluntary registry of patients treated with commercial metreleptin including, but not limited to, patients in the US and EEA.
Participants needed: 100
Trial details
Biological sex: AllType: ObservationalSponsor: Amryt PharmaUpdated: Jan 20, 2026Locations: 28Duration: 10 Years
Eligibility criteria
Patients treated with metreleptin through commercial supply at the time or befor... [+2]